Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14

1.

High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.

DeZern AE, Petri M, Drachman DB, Kerr D, Hammond ER, Kowalski J, Tsai HL, Loeb DM, Anhalt G, Wigley F, Jones RJ, Brodsky RA.

Medicine (Baltimore). 2011 Mar;90(2):89-98. doi: 10.1097/MD.0b013e318210e685.

2.

High-dose cyclophosphamide for aplastic anemia and autoimmunity.

Brodsky RA.

Curr Opin Oncol. 2002 Mar;14(2):143-6. Review.

PMID:
11880702
3.

High dose cyclophosphamide treatment for autoimmune disorders.

Brodsky RA.

ScientificWorldJournal. 2002 Jun 28;2:1808-15. Review.

4.
5.

Cyclophosphamide and other new agents for the treatment of severe aplastic anemia.

Tisdale JF, Dunn DE, Maciejewski J.

Semin Hematol. 2000 Jan;37(1):102-9. Review.

PMID:
10676915
6.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
7.

High-dose cyclophosphamide for autoimmunity and alloimmunity.

Brodsky RA.

Immunol Res. 2010 Jul;47(1-3):179-84. doi: 10.1007/s12026-009-8149-y. Review.

PMID:
20087683
8.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
9.
10.

Aplastic anaemia.

Brodsky RA, Jones RJ.

Lancet. 2005 May 7-13;365(9471):1647-56. Review.

PMID:
15885298
11.

Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.

de Masson A, Bouaziz JD, Peffault de Latour R, Benhamou Y, Moluçon-Chabrot C, Bay JO, Laquerrière A, Picquenot JM, Michonneau D, Leguy-Seguin V, Rybojad M, Bonnotte B, Jardin F, Lévesque H, Bagot M, Socié G.

Medicine (Baltimore). 2013 Mar;92(2):69-81. doi: 10.1097/MD.0b013e3182899e78. Review.

12.

[New possibilities of treating patients with autoimmune disorders].

Gergely P, Fekete B.

Orv Hetil. 2007 Apr 8;148 Suppl 1:58-62. Review. Hungarian.

PMID:
17430796
13.

Potential role of immunoablation and hematopoietic cell transplantation in the treatment of early diabetes type 1.

Snarski E, Milczarczyk A, Franek E, Jedrzejczak W.

Ann Transplant. 2010 Jul-Sep;15(3):75-9. Review.

PMID:
20877271
14.

Cyclophosphamide in dermatology.

Kim J, Chan JJ.

Australas J Dermatol. 2016 Jan 24. doi: 10.1111/ajd.12406. [Epub ahead of print] Review.

PMID:
26806212
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk